21 Documents disponibles écrits par cet auteur
This paper provides a brief overview of qualitative drug testing procedures using urine, hair, saliva and sweat specimens. Issues related to collection, analysis and interpretation of each specimen as well as their advantages and disadvantages a[...]
R. P. MATTICK ; C. BREEN ; J. KIMBER ; M. DAVOLI | 2014
Dans Cochrane Database of Systematic Reviews (n°2, 2014) Article : PériodiqueContexte: La méthadone est largement utilisée pour remplacer la consommation d'opiacés illicites, tels que l'héroïne, en traitement d'entretien dans les programmes de prise en charge médicale de la substitution aux opiacés. Deux autres médicamen[...]
L. DEGENHARDT ; B. CLARK ; G. MACPHERSON ; O. LEPPAN ; S. NIELSEN ; E. ZAHRA ; B. LARANCE ; J. KIMBER ; D. MARTINO-BURKE ; M. HICKMAN ; M. FARRELL | 2023
Dans Lancet Psychiatry (The) (Vol.10, n°6, June 2023) Article : PériodiqueBackground: Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and buprenorphine are [...]
J. KIMBER ; K. DOLAN ; I. VAN BEEK ; D. HEDRICH ; H. ZURHOLD | 2003
Dans Drug and Alcohol Review (Vol.22, n°2, June 2003) Article : PériodiqueThe topic of drug consumption facilities or rooms (DCRs) was reviewed by Dolan, Kimber and others in Harm Reduction Digest 10, published in the September 2000 issue of DAR. As one of the first English language papers on the topic this paper has [...]
K. DOLAN ; J. KIMBER ; C. FRY ; J. FITZGERALD ; D. McDONALD ; F. TRAUTMANN | 2000
Dans Drug and Alcohol Review (Vol.19, n°3, September 2000) Article : PériodiqueRooms set aside for the consumption of illicit drugs have been referred to as drug consumption facilities, or rooms, health rooms or injecting rooms in Europe. Terms used in the Australian context include medically supervised injecting centres [...]
L. DEGENHARDT ; N. GISEV ; J. TREVENA ; S. LARNEY ; J. KIMBER ; L. BURNS ; M. SHANAHAN ; D. WEATHERBURN | 2013
Dans Addiction (Vol.108, n°12, December 2013) Article : PériodiqueAims: Studies of offending among people who use drugs typically focus upon small and potentially unrepresentative samples. We examined an entire population of opioid-dependent clients' contact with the criminal justice system to develop more acc[...]
S. LARNEY ; M. HICKMAN ; R. GUY ; J. GREBELY ; G. J. DORE ; R. T. GRAY ; C. A. DAY ; J. KIMBER ; L. DEGENHARDT | 2017
Dans BMC Public Health (Vol.17, n°757, 2017) Article : PériodiqueBackground: Injecting drug use is associated with considerable morbidity and mortality. Estimates of the size of the population of people who inject drugs are critical to inform service planning and estimate disease burden due to injecting drug [...]
N. E. PALMATEER ; J. KIMBER ; M. HICKMAN ; S. HUTCHINSON ; T. RHODES ; D. GOLDBERG | 2010
Dans Addiction (Vol.105, n°5, May 2010) Article : PériodiqueAIMS: To review the evidence on the effectiveness of harm reduction interventions involving the provision of sterile injecting equipment in the prevention of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) transmission among injec[...]
L. DEGENHARDT ; S. LARNEY ; J. KIMBER ; M. FARRELL ; W. HALL | 2015
Dans Drug and Alcohol Review (Vol.34, n°1, January 2015) Article : PériodiqueIntroduction and Aims: To estimate the number of deaths that would have occurred among patients receiving oral naltrexone for opioid use under the Special Access Scheme if these patients had received methadone. Design and Methods: We analysed [...]
V. HOPE ; J. KIMBER ; P. VICKERMAN ; M. HICKMAN ; F. NCUBE | 2008
Dans BMC Infectious Diseases (Vol.8, n°120, 18 September 2008) Article : PériodiqueBACKGROUND: Injection site infections among injecting drug users (IDUs) have been associated with serious morbidity and health service costs in North America. This study explores the frequency, factors and costs associated with injection site in[...]
Supervised injecting centres (SICs) enable the consumption of pre-obtained drugs under hygienic and lower risk conditions. The main objectives are reducing the health and public order problems associated with injecting drug use. With little info[...]
G. J. MACARTHUR ; E. VAN VELZEN ; N. E. PALMATEER ; J. KIMBER ; A. PHARRIS ; V. HOPE ; A. TAYLOR ; K. ROY ; E. ASPINALL ; D. GOLDBERG ; T. RHODES ; D. HEDRICH ; M. SALMINEN ; M. HICKMAN ; S. J. HUTCHINSON | 2014
Dans International Journal of Drug Policy (Vol.25, n°1, January 2014) Article : PériodiqueBACKGROUND: Injecting drug use is a major risk factor for the acquisition and transmission of HIV and Hepatitis C virus (HCV). Prevention of these infections among people who inject drugs (PWID) is critical to reduce ongoing transmission, morbid[...]
R. P. MATTICK ; C. BREEN ; J. KIMBER ; M. DAVOLI | 2009
Dans Cochrane Database of Systematic Reviews (n°3, 2009) Article : PériodiqueBackground: Methadone maintenance was the first widely used opioid replacement therapy to treat heroin dependence, and it remains the best-researched treatment for this problem. Despite the widespread use of methadone in maintenance treatment fo[...]
S. LARNEY ; N. GISEV ; M. FARRELL ; T. A. DOBBINS ; L. BURNS ; A. GIBSON ; J. KIMBER ; L. DEGENHARDT | 2014
Dans BMJ Open (Vol.4, n°4, 2014) Article : PériodiqueObjectives: To describe deaths in prison among opioid-dependent people, and examine associations between receipt of opioid substitution therapy (OST) and risk of death in prison. Design: Retrospective cohort study. Setting: Adult prisons in Ne[...]
T. RHODES ; J. KIMBER ; W. SMALL ; J. FITZGERALD ; T. KERR ; M. HICKMAN ; G. HOLLOWAY | 2006
PériodiqueBackground: One key structural dimension in the distribution of drug-related harm associated with injecting drug use is the injecting environment. Epidemiological evidence associates elevated blood-borne viral risk with injecting in 'public' and[...]
Historique
